Profiling of Antibody Production against Xenograft-released Proteins by Protein Microarrays Discovers Prostate Cancer Markers

被引:12
作者
Jansen, Flip H.
van Rijswijk, Angelique
Teubel, Wilma
van Weerden, Wytske M.
Reneman, Suzanne
van den Bemd, Gert-Jan
Roobol, Monique J.
Bangma, Chris H.
Staal, Frank J. T. [2 ]
Jenster, Guido [1 ]
机构
[1] Erasmus MC, Josephine Nefkens Inst, Dept Urol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Immunol, NL-3000 CA Rotterdam, Netherlands
关键词
prostate cancer; biomarkers; xenograft; protoarray; TYROSINE KINASE; MODEL SYSTEM; SERUM; IDENTIFICATION; PROTEASOME; BIOMARKER; ANTIGEN;
D O I
10.1021/pr2006473
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This study describes a novel xenograft-based biomarker discovery platform and proves its usefulness in the discovery of serum markers for prostate cancer. By immunizing immuno-competent mice with serum from nude mice bearing prostate cancer xenografts, an antibody response against xenograft-derived antigens was elicited. By probing protein microarrays with serum from immunized mice, several prostate cancer-derived antigens were identified, of which a subset was successfully retrieved in serum from mice bearing prostate cancer xenografts and prevalidated in human serum samples of prostate cancer patients. Among the discovered and validated proteins were the members of the TAM receptor family (TYRO3, AXL, and MERTK), ACY1, and PSMA1. In conclusion, this novel method allows for the identification of low abundant cancer-derived serum proteins, circumventing dynamic range and host-response issues in standard patient cohort proteomics comparisons.
引用
收藏
页码:728 / 735
页数:8
相关论文
共 28 条
[1]   The proteasome: structure, function, and role in the cell [J].
Adams, J .
CANCER TREATMENT REVIEWS, 2003, 29 :3-9
[2]   2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer [J].
Byrne, Jennifer C. ;
Downes, Michelle R. ;
O'Donoghue, Niaobh ;
O'Keane, Conor ;
O'Neill, Amanda ;
Fan, Yue ;
Fitzpatrick, John M. ;
Dunn, Michael J. ;
Watson, R. William G. .
JOURNAL OF PROTEOME RESEARCH, 2009, 8 (02) :942-957
[3]   INDIVIDUAL VARIATIONS OF THE IMMUNE-RESPONSE IN BALB/C MICE [J].
DANILOVA, NP ;
MERTTS, MV ;
SOROKOLIT, TP ;
VASILOV, RG .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1995, 119 (01) :74-76
[4]   Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma [J].
Dutaud, D ;
Aubry, L ;
Henry, L ;
Levieux, D ;
Hendil, KB ;
Kuehn, L ;
Bureau, JP ;
Ouali, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 260 (1-2) :183-193
[5]   A mouse to human search for plasma Proteome changes associated with pancreatic tumor development [J].
Faca, Vitor M. ;
Song, Kenneth S. ;
Wang, Hong ;
Zhang, Qing ;
Krasnoselsky, Alexei L. ;
Newcomb, Lisa F. ;
Plentz, Ruben R. ;
Gurumurthy, Sushma ;
Redston, Mark S. ;
Pitteri, Sharon J. ;
Pereira-Faca, Sandra R. ;
Ireton, Renee C. ;
Katayama, Hiroyuki ;
Glukhova, Veronika ;
Phanstiel, Douglas ;
Brenner, Dean E. ;
Anderson, Michelle A. ;
Misek, David ;
Scholler, Nathalie ;
Urban, Nicole D. ;
Barnett, Matt J. ;
Edelstein, Cim ;
Goodman, Gary E. ;
Thornquist, Mark D. ;
McIntosh, Martin W. ;
DePinho, Ronald A. ;
Bardeesy, Nabeel ;
Hanash, Samir M. .
PLOS MEDICINE, 2008, 5 (06) :953-967
[6]   PRODUCTION OF ANTIBODIES AGAINST ANTIGENS RELEASED FROM HUMAN PANCREATIC TUMOR XENOGRAFTS [J].
GRANT, AG ;
DUKE, D .
BRITISH JOURNAL OF CANCER, 1981, 44 (03) :388-395
[7]   Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry [J].
Harper, RG ;
Workman, SR ;
Schuetzner, S ;
Timperman, AT ;
Sutton, JN .
ELECTROPHORESIS, 2004, 25 (09) :1299-1306
[8]  
HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809
[9]   High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance [J].
Hortin, Glen L. ;
Sviridov, Denis ;
Anderson, N. Leigh .
CLINICAL CHEMISTRY, 2008, 54 (10) :1608-1616
[10]  
Jacob ANK, 1999, CANCER DETECT PREV, V23, P325